Follow the 삼진제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼진제약 has published 89 reports. The latest transaction was reported on 25 August 2026 (Purchase). Among the most active insiders: 전상진. The full history is free.
76
Insider Decl.
n/a
Thresholds
n/a
43 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Samjin Pharmaceutical es una empresa farmacéutica surcoreana centrada en la investigación, el desarrollo y la fabricación de medicamentos. Cotiza en la Bolsa de Corea, XKRX.